05:36 PM EDT, 10/23/2024 (MT Newswires) -- Saurabh Saha, Director, Chief Executive Officer, on October 21, 2024, sold 55,000 shares in Centessa Pharmaceuticals ( CNTA ) for $863,727. Following the Form 4 filing with the SEC, Saha has control over a total of 668,661 shares of the company, with 630,661 shares held directly and 38,000 controlled indirectly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1847903/000184790324000160/xslF345X05/wk-form4_1729718836.xml